КОМПЛЕКСНАЯ ТЕРАПИЯ ЭПШТЕЙНА-БАРР-ВИРУСНОЙ ИНФЕКЦИИ У ДЕТЕЙ
Treatment of patients with infectious mononucleosis is currently difficult because none of the known antiviral drugs can completely eliminate the virus from the organism. Promising is the use of genetically engineered recombinant α-interferon (Viferon®) with a complex antiviral, antibacterial, antip...
Main Authors: | Л. В. Крамарь, О. А. Карпухина |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2012-02-01
|
Series: | Архивъ внутренней медицины |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/48 |
Similar Items
-
Rare case of Visceral form of Infectious Mononucleosis in Irkutsk Region
by: N. K. Bobrova, et al.
Published: (2019-01-01) -
Infectious mononucleosis by Epstein-Barr virus: A complete laboratory picture
by: Marco P.Barros Pinto
Published: (2024-04-01) -
INFLUENCE OF CYCLOFERON ON THE CELLULAR SUSCEPTIBILITY TO INTERFERON-α2 IN VITRO IN PATIENTS WITH INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN– BARR VIRUS
by: L. M. Kurtasova, et al.
Published: (2018-12-01) -
Angioedema Related to Infectious Mononucleosis
by: Duygu Lüleci Dağlı, et al.
Published: (2022-06-01) -
Epstein-Barr Virus Neurologic Complications
by: J. Gordon Millichap
Published: (2015-12-01)